CIDOFOVIR DIHYDRATE (Heritage Pharmaceuticals Inc.)


Welcome to the PulseAid listing for the CIDOFOVIR DIHYDRATE drug offered from Heritage Pharmaceuticals Inc.. This Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Heritage Pharmaceuticals Inc.
NON-PROPRIETARY NAME: CIDOFOVIR DIHYDRATE
SUBSTANCE NAME: CIDOFOVIR
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],DNA Polymerase Inhibitors [MoA],Nucleoside Analog [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2012-08-06
END MARKETING DATE: 0000-00-00


CIDOFOVIR DIHYDRATE HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCIDOFOVIR DIHYDRATE from Heritage Pharmaceuticals Inc.
LABELER NAME: Heritage Pharmaceuticals Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 375(mg/5mL)
START MARKETING DATE: 2012-08-06
END MARKETING DATE: 0000-00-00
PRODUCT ID: 23155-216_620d12cb-e8ab-4a4b-a22e-df505e84c3d0
PRODUCT NDC: 23155-216
APPLICATION NUMBER: ANDA202501

Other CIDOFOVIR Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Gilead Sciences, Inc.Vistide
Heritage Pharmaceuticals Inc.CIDOFOVIR DIHYDRATE
Mylan Institutional LLCCidofovir